![]() |
市場調查報告書
商品編碼
1368677
生理食鹽水市場規模 - 藥物類型(生理食鹽水、低滲透壓)、包裝類型(軟袋、塑膠瓶)、應用(慢性病、急性健康狀況)、最終用戶、全球預測 2023 - 2032Physiological Saline Market Size - Drug Type (Normal Saline, Hypotonic), Packaging Type (Flexible Bag, Plastic Bottle), Application (Chronic Disease, Acute Health Conditions), End-user, Global Forecast 2023 - 2032 |
2023 年至 2032 年間,全球生理食鹽水市場年複合成長率將達到 6.2%。它仍然是醫療保健的重要組成部分,對於靜脈輸液、傷口清潔和診斷程序至關重要。此外,慢性病和外科手術的盛行率不斷上升,導致對鹽溶液的需求增加。
例如,根據世界衛生組織 2023 年 9 月的統計數據,非傳染性疾病 (NCD) 每年奪走 4,100 萬人的生命,佔全球總死亡率的 74%。此外,每年有 1700 萬人在 70 歲之前死於非傳染性疾病,凸顯了這些疾病對過早死亡的重大影響。此外,COVID-19 大流行凸顯了其在呼吸護理方面的用途。隨著患者健康意識的增強,人們對天然和安全產品的偏好日益增強,增加了對生理食鹽水的需求。這些因素共同推動生理食鹽水市場前景。
整個生理食鹽水市場根據應用、最終用戶和地區進行分類。
2023年至2032年,慢性病領域將經歷重大發展。這種無菌且平衡的鹽溶液在糖尿病、腎臟病和心血管問題等各種慢性健康狀況的治療和管理中發揮關鍵作用。隨著全球慢性病負擔持續加重,生理食鹽水市場需求依然強勁,成為醫療保健中不可或缺的一部分。
門診手術中心部分從 2023 年到 2032 年將實現值得稱讚的年複合成長率。這些設施專注於門診手術,依賴鹽水溶液進行各種醫療應用,包括術前水合、傷口沖洗和術後護理。隨著 ASC 趨勢持續成長,生理食鹽水市場佔有率仍然強勁,支持其在這些環境中提供安全有效的醫療保健方面發揮關鍵作用。
歐洲生理食鹽水市場從 2023 年到 2032 年將呈現可觀的年複合成長率。隨著慢性病盛行率的上升,歐洲大陸的人口老化加劇了醫療保健環境中對生理食鹽水解決方案的需求。例如,根據歐盟統計局的一份報告,基於年齡的預測表明,到2050 年,歐盟27 國預計將有近50 萬百歲老人。歐洲的高醫療保健標準與嚴格的安全法規相結合,強調了這一重要性。生理食鹽水。隨著醫療實踐的不斷發展,歐洲醫療保健領域對這種基本醫療產品的需求仍然強勁。
Global Physiological Saline Market will witness 6.2% CAGR between 2023 and 2032. it remains a crucial component in healthcare, essential for intravenous fluids, wound cleansing, and diagnostic procedures. In addition, the rising prevalence of chronic diseases and surgical interventions contributes to increased demand for saline solutions.
For instance, according to September 2023 stats from WHO, noncommunicable diseases (NCDs) claim the lives of 41 million individuals annually, accounting for 74% of the total global mortality. Furthermore, each year, 17 million people succumb to NCDs before reaching the age of 70, underscoring the significant impact of these diseases on premature mortality. Furthermore, the COVID-19 pandemic highlighted its use for respiratory care. As patients become more health-conscious, there's a growing preference for natural and safe products, boosting the demand for physiological saline solutions. These factors collectively propel the physiological saline market outlook.
The overall Physiological Saline Market is classified based on application, end-user, and region.
The chronic diseases segment will undergo significant development from 2023 to 2032. This sterile and balanced salt solution plays a pivotal role in the treatment and management of various chronic health conditions, such as diabetes, kidney disease, and cardiovascular issues. As the global burden of chronic diseases continues to rise, the physiological saline market demand remains robust, making it an indispensable component in healthcare.
The ambulatory surgical centers segment will register a commendable CAGR from 2023 to 2032. These facilities, focused on outpatient procedures, rely on saline solutions for various medical applications, including pre-operative hydration, wound irrigation, and post-operative care. As the trend toward ASCs continues to grow, the physiological saline market share remains strong, supporting its crucial role in providing safe and effective healthcare in these settings.
Europe physiological saline market will showcase an appreciable CAGR from 2023 to 2032. The continent's aging population, in line with a rising prevalence of chronic diseases, fuels the need for saline solutions in healthcare settings. For instance, according to a report from Eurostat, an age-based projection indicates that the EU-27 is expected to have nearly 500,000 centenarians by the year 2050. The high healthcare standards in Europe, in tandem with stringent safety regulations, emphasize the significance of physiological saline. As medical practices continue to evolve, the demand for this essential medical product remains robust in the European healthcare landscape.